Aspects that facilitate access to care for viral hepatitis: an evaluative research
Keywords:
Comprehensive health care, Hepatitis, viral, human, Health services, Health services accessibility, Patient acceptance of health care, Governance, Regionalization, Evaluative research in health, Management of health systems and services, Health management, Unified health systemAbstract
BACKGROUND: Viral hepatitis is a major public health concern worldwide.
OBJECTIVES: This study aimed to analyze the factors that facilitate access to care for viral hepatitis.
DESIGN AND SETTING: Using a sequential mixed method, this evaluation research was conducted in the state of Mato Grosso, Brazil.
METHODS: Mapping of references and selection of regions were made based on the quantity and heterogeneity of services. The stakeholders, including the managers of the State Department of Health and professionals from reference services, were identified. Nine semi-structured interviews were conducted using content analysis and discussions guided by the dimensions of the analysis model of universal access to health services.
RESULTS: In the political dimension, decentralizing services and adhering to the Intermunicipal Health Consortium are highly encouraged. In the economic-social dimension, a commitment exists to allocate public funds for the expansion of referral services and subsidies to support users in their travel for appointments, medications, and examinations. In the organizational dimension, the availability of inputs for testing, definition of user flow, ease of scheduling appointments, coordination by primary care in testing,
collaboration following the guidelines and protocols, and engagement in extramural activities are guaranteed. In the technical dimension, professionals actively commit to the service and offer different opening hours, guarantee the presence of an infectious physician, expand training opportunities, and establish intersectoral partnerships. In the symbolic dimension, professionals actively listen to the experiences of users throughout their care trajectory and demonstrate empathy.
CONCLUSIONS: The results are crucial for improving comprehensiveness, but necessitate managerial efforts to enhance regional governance.
Downloads
References
Xiang Z, Li J, Lu D, Wei X, Xu X. Advances in multi-omics research on viral hepatitis. Front Microbiol. 2022;13:987324. PMID: 36118247; https:// doi.org/10.3389/fmicb.2022.987324.
Organização Pan-Americana da Saúde. Dia Mundial da Hepatite 2020: “Um Futuro Livre de Hepatite”. Available from: https://www.paho.org/ pt/noticias/9-9-2020-dia-mundial-da-hepatite-2020-um-futuro-livrehepatite. Accessed in 2023 (Jan. 8).
Brasil. Boletim Epidemiológico Hepatites Virais 2022. Brasília-DF: Ministério da Saúde; 2022. Available from: https://pncq.org.br/ wp-content/uploads/2022/08/boletim_hepatites_virais_2022_ internet_003.pdf. Accessed in 2023 (Mar. 13).
Organização Mundial da Saúde. Estrategia mundial del sector de la salud contra las hepatitis víricas 2016-2021: hacia el fin de las hepatitis víricas. Geneva: OPAS; 2016. Available from: http://apps.who.int/iris/bitstream/ handle/10665/250578/WHO-HIV-2016.06-%20spa.pdf?sequence=1. Accessed in 2023 (Mar. 13).
Organização Pan-Americana da Saúde. Dia Mundial da Hepatite 2020: “Um Futuro Livre de Hepatite”. Washington: OPAS; 2016. Available from: https:// iris.paho.org/bitstream/handle/10665.2/31447/9789275319291-%20 spa.pdf?sequence=5&isAllowed=y. Accessed in 2023 (Jan. 8).
Cooke GS. Descentralisation, integration, and task-shifting: tools to accelerate the elimination of hepatitis C. Lancet Glob Health. 2021;9(4):e375-6. PMID: 33639098; https://doi.org/10.1016/s2214-109x(21)00055-3.
Organização das Nações Unidas. Objetivos do Desenvolvimento Sustentável. Agenda 2030. Brasília, DF: ONU; 2022. Available from: https://brasil.un.org/pt-br/sdgs. Accessed in 2023 (Mar. 13).
Champagne F, Contandriopoulos AP, Brousselle A, Hartz Z, Denis, JL. A avaliação no campo da saúde: conceitos e métodos. In: Brousselle A, Champagne F, Contandriopoulos AP, Hartz Z, org. Avaliação: conceitos e métodos. Rio de Janeiro: Fiocruz; 2016. p. 41-60.
Fetters MD, Curry LA, Creswell JW. Achieving integration in mixed methods designs-principles and practices. Health Serv Res. 2013;48(6.2):2134-56. PMID: 24279835; https://doi.org/10.1111/1475-6773.12117.
Creswell JW, Plano Clark VL. Designing and conducting mixed methods research. 2nd. Los Angeles: SAGE Publications; 2011.
Gleriano JS. Avaliação de acesso aos serviços de atenção às hepatites virais no estado de Mato Grosso – MT [tese]. Ribeirão Preto: Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo (USP); 2021.
Gleriano JS, Chaves LDP, Ferreira JBB, Forster AC. Processo de descentralização e regionalização da saúde no estado de Mato Grosso. In: França R, Lima MAR, Kapitango-a-Samba KK, et al., org. Políticas públicas regionais: diálogos Norte, Centro-oeste e Nordeste. Curitiba: CRV; 2021. p. 189-228.
Brasil. Ministério da Saúde. Portaria Interministerial nº 1, de 2 de janeiro de 2014. Institui a Política Nacional de Atenção Integral à Saúde das Pessoas Privadas de Liberdade no Sistema Prisional (PNAISP) no âmbito do Sistema Único de Saúde (SUS). Diário Oficial da União. 2014;2(1):2. Available from: https://bvsms.saude.gov.br/bvs/saudelegis/gm/2014/ pri0001_02_01_2014.html. Accessed in 2023 (Mar. 14).
Braun V, Clarke V, Gray D. Coleta de dados qualitativos: Um guia prático para técnicas textuais, midiáticas e virtuais. Petrópolis: Vozes; 2019.
Minayo MCS, Assis SG, Souza ER. Avaliação por triangulação de métodos:
abordagem de programas sociais. Rio de Janeiro: Fiocruz; 2010.
Assis MMA, Jesus WLA. Acesso aos serviços de saúde: abordagens, conceitos, políticas e modelo de análise. Ciênc Saúde Colet. 2012;17(11):2865-75. PMID: 23175292; https://doi.org/10.1590/s141381232012001100002.
Ouma PO, Maina J, Thuranira PN, et al. Access to emergency hospital care provided by the public sector in sub-Saharan Africa in 2015: a geocoded inventory and spatial analysis. Lancet Glob Health. 2018;6(3):e342-50. PMID: 29396220; https://doi.org/10.1016/s2214-109x(17)30488-6.
Zimmermann R, Külper-Schiek W, Steffen G, et al. How to assess the elimination of viral hepatitis B, C, and D in Germany? Outcomes of an interdisciplinary workshop. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021;64(1):77-90. PMID: 33326051; https://doi.org/10.1007/s00103-020-03260-2.
Papatheodoridis GV, Hatzakis A, Cholongitas E, et al. Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe. J Viral Hepat. 2018;25(suppl 1):6-17. PMID: 29508946; https://doi.org/10.1111/jvh.12875.
Organização Mundial da Saúde. Accelerating access to hepatitis C diagnostics and treatment; overcoming barriers in lowand middleincome countries. Available from: https://apps.who.int/iris/bitstream/ha ndle/10665/338901/9789240019003-eng.pdf. Accessed in 2023 (Oct. 06).
Ministério da Saúde. Prevenção e controle das IST, do HIV/Aids e das hepatites virais: Plano para eliminação da hepatite C no Brasil. Brasília: Ministério da Saúde; 2019. Available from: http://www.aids.gov.br/ptbr/pub/2019/plano-para-eliminacao-dahepatite-c-no-brasil. Accessed in 2023 (Oct. 06).
Ximenes RAA, Figueiredo GM, Cardoso MRA, Stein AT, Moreira RC, Coral G, et al. Population-Based Multicentric Survey of Hepatitis B Infection and Risk Factors in the North, South, and Southeast Regions of Brazil, 10-20 Years After the Beginning of Vaccination. Am J Trop Med Hyg. 2015;93(6):1341-48. PMID: 26503280; https://doi.org/10.4269/ ajtmh.15-0216.
Mesquita F, Santos ME, Benzaken A, et al. The Brazilian comprehensive response to hepatitis C: from strategic thinking to access to interferonfree therapy. BMC Public Health. 2016;16(1):1132. PMID: 27806712; https://doi.org/10.1186/s12889-016-3784-4.
Brasil. Ministério da Saúde. Portaria n° 1.537, de 12 de junho de 2020. Altera a Portaria de Consolidação nº 5, de 28 de setembro de 2017, para dispor sobre o Programa Nacional para a Prevenção e o Controle das Hepatites Virais e a Portaria de Consolidação nº 6, de 28 de setembro de 2017, para incluir os medicamentos do Programa Nacional para a Prevenção e o Controle das Hepatites Virais no Componente Estratégico da Assistência Farmacêutica. Diário Oficial da União. 2020;112(1):140. Available from: https://www.in.gov.br/en/web/dou/-/portaria-n-1.537de-12-de-junho-de-2020-261498866. Accessed in 2023 (Mar. 14).
Oru E, Trickey A, Shirali R, Kanters S, Easterbrook P. Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis. Lancet Glob Health. 2021;9(4):e431-45. PMID: 33639097; https://doi.org/10.1016/ s2214-109x(20)30505-2.
Sarzi M, Moreno F, Ogama C. Serviço ambulatorial/S.T.A. Hepatite. Anais do 13º Congresso Internacional da Rede Unida; 2018;4(suppl 1). Disponível em: http://conferencia2018.redeunida.org.br/ocs2/ index.php/eventos/cismepar/paper/view/5787. Accessed in 2023 (Mar. 14).
Mennini FS, Marcellusi A, Robbins Scott S, et al. The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four European countries. Liver Int. 2021;41(5):934-48. PMID: 33529499; https://doi.org/10.1111/liv.14808.
Mangia A, Cotugno R, Cocomazzi G, Squillante MM, Piazzolla V. Hepatitis C virus micro-elimination: Where do we stand? World J Gastroenterol. 2021;27(16):1728-37. PMID: 33967553; https://doi.org/10.3748/wjg.v27. i16.1728.
Chen L, Yang Y, Luo M, et al. The impacts of national centralized drug procurement policy on drug utilization and drug expenditures: the case of Shenzhen, China. Int J Environ Res Public Health. 2020;17(24):9415. PMID: 33334027; https://doi.org/10.3390/ijerph17249415.
Pérez AV, Trujillo AJ, Mejia AE, Contreras JD, Sharfstein JM. Evaluating the centralized purchasing policy for the treatment of hepatitis C: The Colombian CASE. Pharmacol Res Perspect. 2019;7(6):e00552. PMID: 31857910; https://doi.org/10.1002/prp2.552.
Chaves GC, Castro CGSO, Oliveira MA. Public procurement of hepatitis C medicines in Brazil from 2005 to 2015. Cien Saude Colet. 2017;22(8):2527-38. PMID: 28793069; https://doi.org/10.1590/141381232017228.05602017.
Gomes LO, Teixeira MR, Rosa JA, et al. Hepatitis C in Brazil: lessons learned with boceprevir and telaprevir. Rev Inst Med Trop Sao Paulo. 2018;60:e29. PMID: 29972466; https://doi.org/10.1590/s1678-9946201860029.
Zhou K, Fitzpatrick T, Walsh N, et al. Interventions to optimize the care continuum for chronic viral hepatitis: a systematic review and metaanalyses. Lancet Infect Dis. 2016;16(12):1409-22. PMID: 27615026; https://doi.org/10.1016/s1473-3099(16)30208-0.
Benzaken AS, Girade R, Catapan E, et al. Hepatitis C disease burden and strategies for elimination by 2030 in Brazil. A mathematical modeling approach. Braz J Infect Dis. 2019;23(3):182-90. PMID: 31145876; https:// doi.org/10.1016/j.bjid.2019.04.010.
Freitas Neta ACS, Ferreira EF, Silva TC, Paulo FS, Fontes PSS. O acesso ao tratamento fora de domicílio dos pacientes do município de Três Rios: limites, desafios e possibilidades. Rev Interd Pens Cient. 2020;5(4):130518. Available from: http://143.244.166.130/index.php/reinpec/article/ view/467. Accessed in 2023 (Mar. 14).
Gurjão FM, Maia LFRB, Carvalho MFSL. Tratamento fora de domicílio: perspectivas dos pacientes do transplante renal de um hospital universitário. Serv Soc Saúde. 2018;17(1):155-80. https://doi. org/10.20396/sss.v17i1.8655206.
Sherbuk JE, Knick TK, Canan C, et al. Development of an interdisciplinary telehealth model of provider training and comprehensive care for hepatitis C and opioid use disorder in a high-burden region. J Infect Dis. 2020;222(suppl 5):s354-64. PMID: 32877562; https://doi.org/10.1093/ infdis/jiaa141.
Otero MA, Liu CH, Apuero J, et al. Peer-to-peer sessions in primary care to improve the hepatitis B detection rate in Seville, Spain.
Ann Hepatol. 2018;17(5):864-70. PMID: 30145574; https://doi. org/10.5604/01.3001.0012.3162.
Lambert JS, Murtagh R, Menezes D, et al. ‘HepCheck Dublin’: an intensified hepatitis C screening programme in a homeless population demonstrates the need for alternative models of care. BMC Infect Dis. 2019;19(1):128. PMID: 30732573; https://doi.org/10.1186/12879-0193748-2.
Rocha KB, Santos RRG, Conz J, Silveira ACT. Transversalizando a rede: o matriciamento na descentralização do aconselhamento e teste rápido para HIV, sífilis e hepatites. Saúde Debate. 2016;40(109):22-33. http:// doi.org/10.1590/0103-1104201610902.
Zuckerman A, Carver A, Chastain CA. Building a hepatitis C clinical program: strategies to optimize outcomes. Curr Treat Options Infect Dis. 2018;10(4):431-46. PMID: 30524209; https://doi.org/10.1007/s40506018-0177-5.
Brasil. Ministério Extraordinário da Segurança Pública. Resolução nº 3, de 7 junho de 2018. Diário Oficial da União. 2018;112(1):78. Available from: https://www.in.gov.br/materia/-/asset_publisher/Kujrw0TZC2Mb/ content/id/25404881/do1-2018-06-13-resolucao-n-3-de-7-junhode-2018-25404825.
Schultz ALV, Dotta RM, Stock BS, Dias MTG. Limites e desafios para o acesso das mulheres privadas de liberdade e egressas do sistema prisional nas Redes de Atenção à Saúde. Physis. 2020;30(3):e300325. https://doi.org/10.1590/s0103-73312020300325.
Connolly SP, Avramovic G, Cullen W, et al. HepCare Ireland-a service innovation project. Ir J Med Sci. 2021;190(2):587-95. PMID: 32761548; https://doi.org/10.1007/s11845-020-02324-1.
Glaspy S, Avramovic G, McHugh T, et al. Exploring and understanding HCV patient journeys- HEPCARE Europe project. BMC Infect Dis. 2021;21(1):239. PMID: 33673828; https://doi.org/10.1186/s12879-02105928-9.
Tucker JD, Meyers K, Best J, et al. The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testing. BMC Infect Dis. 2017;17(suppl 1):701. PMID: 29143673; https://doi.org/10.1186/ s12879-017-2771-4.
Mehta SJ, Day SC, Norris AH, et al. Behavioral interventions to improve population health outreach for hepatitis C screening: randomized clinical trial. BMJ. 2021;373:n1022. PMID: 34006604; https://doi. org/10.1136/bmj.n1022.
Murphy M, Howe K, Marak T, et al. Public health approaches toward eliminating hepatitis C virus in Rhode Island. R I Med J. 2020;103(5):22-5. PMID: 32481775.
McCombe G, Almaazmi B, Cullen W, et al. Integrating primary and secondary care to optimize hepatitis C treatment: development and evaluation of a multidisciplinary educational Masterclass series. J Antimicrob Chemother. 2019;74(suppl 5):v24-30. PMID: 31782501; https://doi.org/10.1093/jac/dkz453.
Ajlan AA, Al-Gain R, Ahmed M, et al. Developing a multidisciplinary HCV direct-acting antivirals utilization management and assessment program. J Am Pharm Assoc. 2021;61(2):e159-70. PMID: 33309191; https://doi.org/10.1016/j.japh.2020.11.008.
Geboy AG, Nichols WL, Fernandez SJ, et al. Leveraging the electronic health record to eliminate hepatitis C: Screening in a large integrated healthcare system. PLoS One. 2019;14(5):e0216459. PMID: 31120906; https://doi.org/10.1371/journal.pone.0216459.
Overton K, Clegg J, Pekin F, et al. Outcomes of a nurse-led model of care for hepatitis C assessment and treatment with direct-acting antivirals in the custodial setting. Int J Drug Policy. 2019;72:123-8. PMID: 30967329; https://doi.org/10.1016/j.drugpo.2019.02.013.
Treloar C, Gray R, Brener L. A piece of the jigsaw of primary care: health professional perceptions of an integrated care model of hepatitis C management in the community. J Prim Health Care. 2014;6(2):129-34. PMID: 24892130.
Starbird LE, Budhathoki C, Han HR, et al. Nurse case management to improve the hepatitis C care continuum in HIV co-infection: results of a randomized controlled trial. J Viral Hepat. 2020;27(4):376-86. PMID: 31750598; https://doi.org/10.1111/jvh.13241.
Hamann C, Pizzinato A, Weber JLA, Rocha KB. Narrativas sobre risco e culpa entre usuários e usuárias de um serviço especializado em infecções por HIV: implicações para o cuidado em saúde sexual. Saude Soc. 2017;26(3):651-63. https://doi.org/10.1590/S0104-12902017170669.
Wei D, Xu A, Wu X. The mediating effect of trust on the relationship between doctor-patient communication and patients’ risk perception during treatment. Psych J. 2020;9(3):383-91. PMID: 31795011; https:// doi.org/10.1002/pchj.327.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 São Paulo Medical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
